Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer

Breast Journal

Volumn 11, Issue 3, 2005, Pages 188-194

  Goyal, Amit ^a   Douglas Jones, Anthony G ^a   Newcombe, Robert G ^a   Mansel, Robert E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Breast cancer; Failed localization; False negative rate; Sentinel lymph node biopsy; Tumor burden

Indexed keywords

DYE; TECHNETIUM 99M; TRACER;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER STAGING; HUMAN; LABORATORY DIAGNOSIS; LYMPHOMA; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; METASTASIS; RADIOISOTOPE DISTRIBUTION; SENTINEL LYMPH NODE BIOPSY; STAINING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; SENTINEL LYMPH NODE BIOPSY; STATISTICS, NONPARAMETRIC;

EID: 18644371212     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21591.x     Document Type: Article

References (16)

1. Clarke D, Newcombe RG, Mansel RE. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol 2004;11(3 suppl):S211-15.
2. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-46.
3. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
4. Hsueh EC, Turner RR, Glass EC, et al. Sentinel node biopsy in breast cancer. J Am Coll Surg 1999;189:207-13.
5. Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-59.
6. Mansel RE, Goyal A. European studies on breast lymphatic mapping. Semin Oncol 2004;31:303-10.
7. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-97.
8. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 1999;52:922-24.
9. Clare SE, Sener SF, Wilkens W, et al. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol 1997;4:447-51.
10. Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999;17:143-49.
11. Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-38.
12. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
13. Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 1999;230:194-201.
14. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001;234:292-99.
15. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229:528-35.
16. National Health Service Breast Screening Programme. 2001/2002 statistics. Available at www.cancerscreening.nhs.uk/breastscreen.